BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9022023)

  • 1. Major histocompatibility complex recognition by immune receptors: differences among T cell receptor versus antibody interactions with the VSV8/H-2Kb complex.
    Witte T; Smolyar A; Spoerl R; Goyarts EC; Nathenson SG; Reinherz EL; Chang HC
    Eur J Immunol; 1997 Jan; 27(1):227-33. PubMed ID: 9022023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topology of T cell receptor-peptide/class I MHC interaction defined by charge reversal complementation and functional analysis.
    Chang HC; Smolyar A; Spoerl R; Witte T; Yao Y; Goyarts EC; Nathenson SG; Reinherz EL
    J Mol Biol; 1997 Aug; 271(2):278-93. PubMed ID: 9268659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point mutations in the beta chain CDR3 can alter the T cell receptor recognition pattern on an MHC class I/peptide complex over a broad interface area.
    Goyarts EC; Vegh Z; Kalergis AM; Hörig H; Papadopoulos NJ; Young AC; Thomson CT; Chang HC; Joyce S; Nathenson SG
    Mol Immunol; 1998 Jul; 35(10):593-607. PubMed ID: 9823758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A molecular basis for how a single TCR interfaces multiple ligands.
    Boesteanu A; Brehm M; Mylin LM; Christianson GJ; Tevethia SS; Roopenian DC; Joyce S
    J Immunol; 1998 Nov; 161(9):4719-27. PubMed ID: 9794402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of an MHC class I-restricted antigenic peptide can be modulated by para-substitution of its buried tyrosine residues in a TCR-specific manner.
    Saito NG; Chang HC; Paterson Y
    J Immunol; 1999 May; 162(10):5998-6008. PubMed ID: 10229839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. V beta 5+ T cell receptors skew toward OVA+H-2Kb recognition.
    Dillon SR; Jameson SC; Fink PJ
    J Immunol; 1994 Feb; 152(4):1790-801. PubMed ID: 8120388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J; Waks T; Eshhar Z
    Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mode of ligand recognition by two peptide:MHC class I-specific monoclonal antibodies.
    Messaoudi I; LeMaoult J; Nikolić-Zugić J
    J Immunol; 1999 Sep; 163(6):3286-94. PubMed ID: 10477598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TcR recognition of the MHC-peptide dimer: structural properties of a ternary complex.
    Vasmatzis G; Cornette J; Sezerman U; DeLisi C
    J Mol Biol; 1996 Aug; 261(1):72-89. PubMed ID: 8760503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participation of L3T4 in T cell activation in the absence of class II major histocompatibility complex antigens. Inhibition by anti-L3T4 antibodies is a function both of epitope density and mode of presentation of anti-receptor antibody.
    Owens T; Fazekas de St Groth B
    J Immunol; 1987 Apr; 138(8):2402-9. PubMed ID: 2435798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of major histocompatibility complex class I-restricted hapten recognition by mutation of the V-J joining of T cell receptor alpha chains.
    von Bonin A; Plaga S; Ruh H; Hebbelmann S; Pflugfelder U; Martin S; Weltzien HU
    Eur J Immunol; 1996 Jan; 26(1):179-86. PubMed ID: 8566064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-positive T cell receptor(high) thymocytes are resistant to peptide/major histocompatibility complex ligand-induced negative selection.
    Ghendler Y; Hussey RE; Witte T; Mizoguchi E; Clayton LK; Bhan AK; Koyasu S; Chang HC; Reinherz EL
    Eur J Immunol; 1997 Sep; 27(9):2279-89. PubMed ID: 9341770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of radiation leukemia viruses to a thymic lymphoma involves some class I molecules on the T cell as well as the T cell receptor complex.
    O'Neill HC
    J Mol Cell Immunol; 1989; 4(4):213-23. PubMed ID: 2558669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structures of murine MHC Class I H-2 D(b) and K(b) molecules in complex with CTL epitopes from influenza A virus: implications for TCR repertoire selection and immunodominance.
    Meijers R; Lai CC; Yang Y; Liu JH; Zhong W; Wang JH; Reinherz EL
    J Mol Biol; 2005 Feb; 345(5):1099-110. PubMed ID: 15644207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide variants reveal how antibodies recognize major histocompatibility complex class I.
    Hogquist KA; Grandea AG; Bevan MJ
    Eur J Immunol; 1993 Nov; 23(11):3028-36. PubMed ID: 8223880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral escape at the molecular level explained by quantitative T-cell receptor/peptide/MHC interactions and the crystal structure of a peptide/MHC complex.
    Tissot AC; Ciatto C; Mittl PR; Grütter MG; Plückthun A
    J Mol Biol; 2000 Sep; 302(4):873-85. PubMed ID: 10993729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-restricted recognition of viral antigens in HLA transgenic mice.
    Kievits F; Ivanyi P; Krimpenfort P; Berns A; Ploegh HL
    Nature; 1987 Oct 1-7; 329(6138):447-9. PubMed ID: 2821399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in TCR-MHC contacts subsequent to cross-recognition of class I MHC and singly substituted peptide variants.
    Ono T; DiLorenzo TP; Wang F; Kalergis AM; Nathenson SG
    J Immunol; 1998 Nov; 161(10):5454-63. PubMed ID: 9820521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major histocompatibility complex and T cell receptor interaction of the P91A tum- peptide.
    McCormick D; Stauss HJ; Thorpe C; Travers P; Dyson PJ
    Eur J Immunol; 1996 Dec; 26(12):2895-902. PubMed ID: 8977283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule.
    Tynan FE; Reid HH; Kjer-Nielsen L; Miles JJ; Wilce MC; Kostenko L; Borg NA; Williamson NA; Beddoe T; Purcell AW; Burrows SR; McCluskey J; Rossjohn J
    Nat Immunol; 2007 Mar; 8(3):268-76. PubMed ID: 17259989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.